# THE NIH NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - NEW CLINICAL SITE

> **NIH NIH N01** · WASHINGTON UNIVERSITY · 2024 · $1,850,908

## Abstract

The purpose of this contract is to establish a new National NeuroHIV Tissue Consortium (NNTC) Clinical site as a critical resource for catalyzing high priority research in NeuroHIV (CNS complications in people with HIV), including studies to understand the mechanisms of HIV neuropathogenesis, aging with long-term HIV and ART, and research towards an HIV cure. The NNTC clinical site shall collect, store, and provide clinical data and well characterized biological specimens, including antemortem/ postmortem tissue from study volunteers and/or organ donors with HIV as well as HIV-negative controls. The establishment of a new NNTC clinical site is necessary to ensure geographic diversity in the southern and
midwestern United States that are actively being sought.

## Key facts

- **NIH application ID:** 11222446
- **Project number:** 75N95024C00027-0-9999-1
- **Recipient organization:** WASHINGTON UNIVERSITY
- **Principal Investigator:** Beau M Ances
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,850,908
- **Award type:** —
- **Project period:** 2024-09-23 → 2025-09-22

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11222446

## Citation

> US National Institutes of Health, RePORTER application 11222446, THE NIH NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - NEW CLINICAL SITE (75N95024C00027-0-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11222446. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*